Temporal lobe epilepsy (TLE) is the most common form of drug-resistant focal epilepsy (DRE) and accounts for two-thirds of all patients with intractable epilepsy who undergo surgery. Currently, 30–50% of patients who undergo TLE surgery fail to achieve seizure freedom after five years1,2. There is a paucity of biomarkers for the prognostication of outcomes after epilepsy surgery.
20
MAR
MAR
0